login
login

Europe Daily Bulletin No. 12752

1 July 2021
Contents Publication in full By article 16 / 28
EU RESPONSE TO COVID-19 / Health
Five Covid-19 therapies are under review and already on European Commission’s radar
Brussels, 30/06/2021 (Agence Europe)

Last month, the European Commission committed to identify the five “most promising” Covid-19 therapies by the end of June (see EUROPE B12714A11) in order to best support their development. On Tuesday 29 June, it announced the names of these five solutions.

One of them, baricitinib, is an immunosuppressant distributed by the American company Eli Lilly. It is already on the market, but the company will need to obtain additional market authorisation so that its use can be extended to...

Contents

SECTORAL POLICIES
INSTITUTIONAL
EU RESPONSE TO COVID-19
EXTERNAL ACTION
SECURITY - DEFENCE
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COURT OF JUSTICE OF THE EU
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS